| Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score MM Schoels, D Aletaha, F Alasti, JS Smolen Annals of the rheumatic diseases 75 (5), 811-818, 2016 | 614 | 2016 |
| Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease G Slavka, T Perkmann, H Haslacher, S Greisenegger, C Marsik, ... Arteriosclerosis, thrombosis, and vascular biology 31 (5), 1215-1218, 2011 | 402 | 2011 |
| Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial R Bartsch, AS Berghoff, J Furtner, M Marhold, ES Bergen, S Roider-Schur, ... Nature medicine 28 (9), 1840-1847, 2022 | 388 | 2022 |
| A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection F Eskandary, H Regele, L Baumann, G Bond, N Kozakowski, ... Journal of the American Society of Nephrology 29 (2), 591-605, 2018 | 328 | 2018 |
| SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity D Mrak, S Tobudic, M Koblischke, M Graninger, H Radner, D Sieghart, ... Annals of the rheumatic diseases 80 (10), 1345-1350, 2021 | 262 | 2021 |
| Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays T Perkmann, N Perkmann-Nagele, T Koller, P Mucher, A Radakovics, ... Microbiology spectrum 9 (1), 10.1128/spectrum. 00247-21, 2021 | 205 | 2021 |
| SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response MM Bonelli, D Mrak, T Perkmann, H Haslacher, D Aletaha Annals of the rheumatic diseases 80 (10), 1355-1356, 2021 | 157 | 2021 |
| Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity T Perkmann, N Perkmann-Nagele, MK Breyer, R Breyer-Kohansal, ... Clinical Chemistry 66 (11), 1405-1413, 2020 | 137 | 2020 |
| Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity F Ratzinger, H Haslacher, W Poeppl, G Hoermann, JJ Kovarik, S Jutz, ... Scientific reports 4 (1), 7438, 2014 | 131 | 2014 |
| CD38 antibody daratumumab for the treatment of chronic active antibody-mediated kidney allograft rejection K Doberer, J Kläger, GA Gualdoni, KA Mayer, F Eskandary, EA Farkash, ... Transplantation 105 (2), 451-457, 2021 | 119 | 2021 |
| Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome S Schnaubelt, J Oppenauer, D Tihanyi, M Mueller, ... Journal of internal medicine 290 (2), 437-443, 2021 | 113 | 2021 |
| Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis D Sieghart, A Platzer, P Studenic, F Alasti, M Grundhuber, S Swiniarski, ... Frontiers in immunology 9, 876, 2018 | 99 | 2018 |
| Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank H Haslacher, M Gerner, P Hofer, A Jurkowitsch, J Hainfellner, R Kain, ... Biopreservation and biobanking 16 (6), 477-482, 2018 | 98 | 2018 |
| Additive gene–environment effects on hippocampal structure in healthy humans U Rabl, BM Meyer, K Diers, L Bartova, A Berger, D Mandorfer, A Popovic, ... Journal of Neuroscience 34 (30), 9917-9926, 2014 | 90 | 2014 |
| Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients F Ratzinger, M Schuardt, K Eichbichler, I Tsirkinidou, M Bauer, ... PloS one 8 (12), e82946, 2013 | 84 | 2013 |
| High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB) J Gebhart, S Hofer, S Panzer, P Quehenberger, R Sunder‐Plassmann, ... Haemophilia 24 (3), 405-413, 2018 | 79 | 2018 |
| Torque teno virus for risk stratification of acute biopsy-proven alloreactivity in kidney transplant recipients R Strassl, K Doberer, S Rasoul-Rockenschaub, H Herkner, I Görzer, ... The Journal of infectious diseases 219 (12), 1934-1939, 2019 | 78 | 2019 |
| Diagnostic contribution of donor-specific antibody characteristics to uncover late silent antibody-mediated rejection—results of a cross-sectional screening study F Eskandary, G Bond, N Kozakowski, H Regele, L Marinova, ... Transplantation 101 (3), 631-641, 2017 | 76 | 2017 |
| Pilot PET study to assess the functional interplay between ABCB1 and ABCG2 at the human blood–brain barrier M Bauer, K Römermann, R Karch, B Wulkersdorfer, J Stanek, C Philippe, ... Clinical Pharmacology & Therapeutics 100 (2), 131-141, 2016 | 73 | 2016 |
| Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations MJ Mair, JM Berger, AS Berghoff, AM Starzer, G Ortmayr, HC Puhr, ... JAMA oncology 8 (1), 106-113, 2022 | 67 | 2022 |
Thomas PerkmannMedical University of Vienna, Department of Laboratory MedicineVerified email at meduniwien.ac.at
